Bleach maker Clorox's Q2 revenue beats estimates

Reuters
Feb 04
Bleach maker Clorox's <a href="https://laohu8.com/S/QTWO">Q2</a> revenue beats estimates

Overview

  • Consumer goods firm's fiscal Q2 revenue beat analyst expectations despite a 1% decline

  • Adjusted EPS for fiscal Q2 missed analyst expectations

Outlook

  • Clorox maintains fiscal year 2026 net sales outlook to decrease 6% to 10%

  • Company expects fiscal year 2026 adjusted EPS between $5.95 and $6.30

  • Clorox anticipates GOJO acquisition to close before fiscal year-end 2026

Result Drivers

  • LOWER CONSUMPTION - Net sales decreased 1% due to lower consumption, partially offset by shipments ahead of consumption

  • HIGHER COSTS - Gross margin decreased due to higher manufacturing and logistics costs, partially offset by cost savings

  • DIGITAL INVESTMENTS - Lower costs related to digital capabilities and productivity enhancements impacted EPS

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$1.67 bln

$1.64 bln (13 Analysts)

Q2 Adjusted EPS

Miss

$1.39

$1.43 (15 Analysts)

Q2 EPS

$1.29

Q2 Gross Margin

43.2%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 14 "hold" and 4 "sell" or "strong sell"

  • The average consensus recommendation for the household products peer group is "buy."

  • Wall Street's median 12-month price target for Clorox Co is $115.00, about 1.5% above its February 2 closing price of $113.29

  • The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago

Press Release: ID:nPn9h7D65a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10